Antineoplastic AgentsAntineoplastic Agents, PhytogenicLeukemia P388Amaryllidaceae AlkaloidsEllipticinesDoxorubicinNarcissusCell Line, TumorBibenzylsDrug Screening Assays, AntitumorAntibiotics, AntineoplasticNeoplasmsAntineoplastic Agents, AlkylatingThiadiazinesBryostatinsNeoplasms, ExperimentalAncitabineCisplatinCell SurvivalGalliumDrug SynergismApoptosisPaclitaxelDepsipeptidesTumor Cells, CulturedTumor Markers, BiologicalTumor BurdenXenograft Model Antitumor Assays6-MercaptopurineTumor Necrosis Factor-alphaCell DivisionEpothilonesAminoacridinesMolecular StructureDose-Response Relationship, DrugCell ProliferationSarcoma 180Leukemia L1210FluorouracilAntimetabolites, AntineoplasticAntineoplastic Combined Chemotherapy ProtocolsLactonesDaunorubicinMice, NudeBleomycinProdrugsEtoposideDrug Evaluation, PreclinicalWilms TumorCell CycleColonic NeoplasmsOvarian NeoplasmsTime FactorsDrug EvaluationCell LineNeoplasm TransplantationBreast NeoplasmsDrug Resistance, NeoplasmGenes, Tumor SuppressorTumor Suppressor Protein p53Drug ResistanceLung NeoplasmsRNA, MessengerCamptothecinMethotrexateEnzyme InhibitorsCarcinoid TumorBrain NeoplasmsStilbenesMacrolidesDrug Administration ScheduleMammary Neoplasms, ExperimentalNeuroendocrine TumorsVincristineTumor Suppressor ProteinsNeovascularization, PathologicCyclophosphamideDNA DamageTumor MicroenvironmentHL-60 CellsCells, CulturedAdenocarcinomaNeoplasm MetastasisKineticsTransplantation, HeterologousBiotransformationIsoquinolinesTreatment OutcomeCarcinoma, Ehrlich TumorClinical Trials as TopicMice, Inbred BALB CLeukemiaCaspasesDrug InteractionsStereoisomerismDNANeoplasm ProteinsGastrointestinal Stromal TumorsDNA, NeoplasmAntigens, Neoplasm